{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:51:09Z","timestamp":1782449469846,"version":"3.54.5"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD) and diabetic retinopathy (DR) represent two major microvascular complications of diabetes mellitus (DM). Previous studies have suggested that renin-angiotensin system inhibitors (RASi) exert protective effects on both DKD and DR. However, their specific impact on retinal microvascular parameters (RMPs), as well as the association between changes in fundus microvasculature and alterations in renal clinical parameters, remains unclear. This pilot study aimed to quantitatively assess the short-term effects of RASi on retinal microvasculature in patients with DKD using an artificial intelligence (AI)-based analysis of ultra-wide-field (UWF) fundus images.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this prospective cohort study, 27 patients with DKD were enrolled between July 2023 and September 2024. UWF fundus images were acquired at baseline and 12 weeks after initiation of RASi therapy. A validated deep learning AI model was employed to segment retinal vessels and quantify RMPs, including fractal dimension (D\n                      <jats:italic>f<\/jats:italic>\n                      ) and tortuosity (TORT), in both the central and peripheral retinal regions. Statistical analyses for pre- and post-treatment comparisons were performed using a linear mixed-effects model with patient ID as a random intercept. or a Wilcoxon signed-rank test, as appropriate. Changes in these parameters post-treatment were analyzed and correlated with alterations in clinical renal indicators.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the enrolled patients, 21 patients (77.8%) were male, with a mean age of 55.7 \u00b1 14.2 years, a mean diabetes duration of 9.9 \u00b1 6.6 years, a baseline estimated glomerular filtration rate (eGFR) of 73.7 \u00b1 18.5 mL\/min\/1.73 m\u00b2, and a median proteinuria of 0.57 (0.25, 0.97) g\/24h. Fifteen patients (55.6%) had diabetic retinopathy (DR). After 12 weeks of RASi treatment, significant decreases were observed within the UWF images in venous D\n                      <jats:italic>f<\/jats:italic>\n                      (adjusted\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.0389) for the overall cohort, and venous TORT (adjusted\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.0496) for No-DR and NPDR groups. These significant changes were not observed in parameters derived from the central retinal region.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RASi therapy might be associated with retinal peripheral venous alterations, providing clues to a vascular- and topography-specific therapeutic response and shedding light on a potential imaging biomarker for diabetes management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1840180","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:37:47Z","timestamp":1782448667000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of RAS inhibitors on retinal microvasculature in DKD using AI-based ultra-wide-field images"],"prefix":"10.3389","volume":"17","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwang","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Molecular Pathology Diagnosis and Translational Research on Rare and Complex Urinary System Diseases","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-s011","article-title":"Chronic kidney disease and risk management: Standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/9781580408387.ch19","article-title":"Retinopathy, neuropathy, and foot care: Standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2022-0074","article-title":"Short-term duration of diabetic retinopathy as a predictor for development of diabetic kidney disease","volume":"11","author":"Duan","year":"2023","journal-title":"J Transl Int Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1336123","article-title":"Parallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy","volume":"15","author":"Tang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-22696-1_8","article-title":"The eye--a window on the kidney","volume":"24","author":"D'Souza","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s1062-1458(01)00549-9","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/cd21-0090","article-title":"Protecting the kidneys: Update on therapies to treat diabetic nephropathy","volume":"40","author":"Davis","year":"2022","journal-title":"Clin Diabetes"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/bf00400359","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/s0140-6736(97)06209-0","article-title":"Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus","volume":"351","author":"Chaturvedi","year":"1998","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2025.110644","article-title":"Diabetic retinopathy as a sentinel of systemic vascular dysfunction: Shared molecular mechanisms with cardiovascular disease","volume":"261","author":"Wang","year":"2025","journal-title":"Exp Eye Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-083405","article-title":"Determining sample size for pilot trials: a tutorial","volume":"390","author":"Ying","year":"2025","journal-title":"Bmj"},{"key":"B14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s40814-023-01416-w","article-title":"A review of sample sizes for UK pilot and feasibility studies on the ISRCTN registry from 2013 to 2020","volume":"9","author":"Totton","year":"2023","journal-title":"Pilot Feasibility Stud"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-023-00660-w","article-title":"Intraocular microbiome in diabetes and diabetic retinopathy: A pilot study","volume":"12","author":"Das","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/ds18-0037","article-title":"Trust and glycemic control in black patients with diabetic retinopathy: A pilot study","volume":"32","author":"Rovner","year":"2019","journal-title":"Diabetes Spectr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41746-024-01271-w","article-title":"Screening chronic kidney disease through deep learning utilizing ultra-wide-field fundus images","volume":"7","author":"Zhao","year":"2024","journal-title":"NPJ Digital Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1109\/tmi.2019.2959609","article-title":"UNet++: Redesigning skip connections to exploit multiscale features in image segmentation","volume":"39","author":"Zhou","year":"2020","journal-title":"IEEE Trans Med Imaging"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7326\/m22-2904","article-title":"Diabetes management in chronic kidney disease: Synopsis of the KDIGO 2022 clinical practice guideline update","volume":"176","author":"Navaneethan","year":"2023","journal-title":"Ann Intern Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170407141955","article-title":"Role of tissue renin-angiotensin system and the chymase\/angiotensin-(1-12) axis in the pathogenesis of diabetic retinopathy","volume":"24","author":"Ola","year":"2017","journal-title":"Curr Med Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.20945\/2359-4292-2023-0292","article-title":"RAAS in diabetic retinopathy: Mechanisms and therapies","volume":"68","author":"Li","year":"2024","journal-title":"Arch Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103089","article-title":"Use of artificial intelligence with retinal imaging in screening for diabetes-associated complications: Systematic review","volume":"81","author":"Yang","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1194320","article-title":"Central and peripheral changes in the retina and choroid in patients with diabetes mellitus without clinical diabetic retinopathy assessed by ultra-wide-field optical coherence tomography angiography","volume":"11","author":"Zhao","year":"2023","journal-title":"Front Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/tvst.10.2.20","article-title":"Relationships between retinal vascular characteristics and renal function in patients with type 2 diabetes mellitus","volume":"10","author":"Zhao","year":"2021","journal-title":"Trans Vision Sci Technol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2018.0182","article-title":"Pathophysiology of diabetic retinopathy: The old and the new","volume":"42","author":"Kusuhara","year":"2018","journal-title":"Diabetes Metab J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4103\/bc.bc_8_23","article-title":"A narrative review of retinal vascular parameters and the applications (Part I): Measuring methods","volume":"9","author":"Gao","year":"2023","journal-title":"Brain Circ"},{"key":"B28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40942-025-00688-z","article-title":"Retinal vessel tortuosity and fractal dimension in diabetic retinopathy","volume":"11","author":"Fathimah","year":"2025","journal-title":"Int J Retina Vitreous"},{"key":"B29","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1186\/s12967-024-05597-7","article-title":"Combining functional and morphological retinal vascular characteristics achieves high-precision diagnosis of mild non-proliferative diabetic retinopathy","volume":"22","author":"Zhang","year":"2024","journal-title":"J Transl Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05388-5","article-title":"Retinal venular tortuosity and fractal dimension predict incident retinopathy in adults with type 2 diabetes: The Edinburgh Type 2 Diabetes Study","volume":"64","author":"Forster","year":"2021","journal-title":"Diabetologia"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2337\/figshare.25577400.v1","article-title":"The early pathogenesis of diabetic retinopathy and its attenuation by sodium-glucose transporter 2 inhibitors","volume":"73","author":"Yamato","year":"2024","journal-title":"Diabetes"},{"key":"B32","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/antiox10060926","article-title":"Oxidative stress mediates vascular tortuosity","volume":"10","author":"Fumoto","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/1120672120979907","article-title":"Retinal vascular tortuosity: Mechanisms and measurements","volume":"31","author":"Vilela","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae204","article-title":"Correlation between retinal vascular geometric parameters and pathologically diagnosed type 2 diabetic nephropathy","volume":"17","author":"Liu","year":"2024","journal-title":"Clin Kidney J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/bf00919281","article-title":"Characterisation of the neovascularisation process in diabetic retinopathy by means of fractal geometry: Diagnostic implications","volume":"231","author":"Daxer","year":"1993","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1167\/iovs.66.4.72","article-title":"Relationships between retinal vascular characteristics and systemic indicators in patients with diabetes mellitus","volume":"66","author":"Xiao","year":"2025","journal-title":"Invest Ophthalmol Visual Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1840180\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:37:51Z","timestamp":1782448671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1840180\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":36,"alternative-id":["10.3389\/fendo.2026.1840180"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1840180","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"1840180"}}